The Opera ofPu-erh tea Picking was the first opera concerning tea.

The Opera ofPu-erh tea Picking was the first opera concerning tea.  but the pessimism permeates the entire industry on the market still has a certain impact. according to the price index of Chinese herbal medicines in China, Chengdu, April 10, 2011 to 2011 May 22 , the price index of Chinese herbal medicines have been around 120 near relatively flat, but nearly two weeks. Chengdu Chinese herbal medicine index shot up again, up 5.84 percentage points, a record high, In this context, the Chinese medicine sector fell comprehensive stocks by the news of the policy impacts behave differently. Conba public offering of corporate bonds is approved.

There were hardly any papers concerningPu-erh tea after the establishment of PRC. the move will help companies improve corporate financial structure, improve asset-liability ratio, the use of tax shields enhance enterprise value, and thus the stock in the second showed a strong eye-level market. Rhine biological production of plant extracts, free from the restrictions of the new EU regulations, has also become one of the recent favorite stocks. We believe that the enterprise of Chinese herbal medicine prices on the part of the base drug types and non-exclusive varieties a certain influence, subjected to raw material price increases at the same time.

Drug-based limit will squeeze their profit margins. stocks, the long-term concern to enter the base drug and exclusive varieties Yunnanbaiyao Mayinglong Tasly, CR thirty-nine, etc., consider the short term, business improved, profitability has improved, The known operas ofPu-erh tea were found and displayed in the past decades. Renhe Pharmaceutical Hokuriku Pharmaceutical, while concerned about the extension of the upstream industry Zhendong pharmaceuticals, purple Xin medicine, Guizhou Braun [biological products the report period, biological products segment decreased by 5.61%.

The same period in pharmaceutical index fell 6.66 percent, the Shanghai Composite Index fell 4.56 percent, biological products segment underperformed the broader market of 1.05 percent, outperforming the 1.05 percent of the pharmaceutical industry stocks, the week or The top three in Changchun Hi-tech (000 661), double-Heron Pharmaceutical, Jinyu Group (600 201), May 23 to May 30 the market and pharmaceutical index in a downward trend, and medical indices and biological products fell more than the broader market, the market from May 31.Pu-erh tea operas are in vogue in many provinces.

To shock consolidation callback compensatory growth is more evident after the pharmaceutical index and biological products oversold. day relative overall trend of the judgment, the market-rail basic in 2700 near the current market in 2700 near the stabilization and recovery, but rebounded whether sustained and rebound strength remains to be seen in this case, medicine as a defensive plate to become the object of attention, including biological products segment oversold in the medicine six sub-plate, is expected to compensatory growth market.  In provinces including Anhui, Fujian, south Gansu, north Guangdong, north Guangxi, Guizhou, west Henan, etc., people are accustomed to putting on shows concerningPu-erh tea.